A Guide to Screening for Autoimmune Diseases in Patients With Vulvar Lichen Sclerosus
Australasian Journal of Dermatology · 2025
DOI: 10.1111/ajd.14434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2025. Verfasst von Annabel Guttentag und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Autoimmune Diseases, Mass Screening. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The aetiology of vulvar lichen sclerosus (VLS) remains unknown. However, there is evidence that in addition to a genetic predisposition, autoimmunity contributes to the pathogenesis.
Objectives
The objective of this study was to determine the prevalence of autoimmune disease and positive autoantibody serology in patients with VLS.
Methods
A VLS database in Sydney, Australia, was retrospectively reviewed. A diagnosis of VLS was required for inclusion in the study. Data collected included demographics, comorbidities including any personal history of autoimmune disease, family history of autoimmune disease, and the results from autoantibody testing. A total of 2243 females with VLS were included in this study.
Results
Autoimmune disease was found in 24.5% and 34.6% of children and adults with VLS, respectively. The most prevalent autoimmune conditions were psoriasis, Hashimoto's thyroiditis, lichen planus, and vitiligo. Antinuclear antibodies were common and found in 31.0% of patients. Thyroid peroxidase and thyroglobulin antibodies were present in 16.1% and 18.9% of cases, respectively. Thyroid function, determined by thyroid stimulating hormone, was abnormal in 8.2% of patients. 5.3% of patients had positive parietal cell antibodies, and 5.9% had low vitamin B12 levels.
Conclusions
This work provides support that VLS is of an autoimmune aetiology, and that there is an association between VLS and autoimmune diseases. The high proportion of patients with an abnormal thyroid test, positive thyroid antibodies, and intrinsic factor and gastric parietal cell antibodies with low vitamin B12 levels, warrants screening for thyroid disease and pernicious anaemia in patients with VLS. Initial autoimmune screening in VLS can be rationalised to TSH, vitamin B12 levels, intrinsic factor and parietal cell antibodies. Thyroid antibodiy testing shouls be performed in hypothyroid patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Sydney, Sydney, New South Wales, Australia.
- Department of Dermatology, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Department of Endocrinology, Royal Prince Alfred Hospital and Bankstown-Lidcombe Hospital, Sydney, New South Wales, Australia.
- Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia.
ORCID-Profile: Annabel Guttentag, Marlene Wijaya, Gayle O Fischer, Angela Lee, Ken Liu
Zitieren
APA
Guttentag, A., Wijaya, M., Fischer, G. O., Lee, A., Liu, K., & Saunderson, R. B. (2025). A Guide to Screening for Autoimmune Diseases in Patients With Vulvar Lichen Sclerosus. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14434
Vancouver
Guttentag A, Wijaya M, Fischer GO, Lee A, Liu K, Saunderson RB. A Guide to Screening for Autoimmune Diseases in Patients With Vulvar Lichen Sclerosus. Australasian Journal of Dermatology. 2025. doi:10.1111/ajd.14434
BibTeX
@article{Guttentag2025,
author = {Guttentag, Annabel and Wijaya, Marlene and Fischer, Gayle O and Lee, Angela and Liu, Ken and Saunderson, Rebecca Bronwyn},
title = {A Guide to Screening for Autoimmune Diseases in Patients With Vulvar Lichen Sclerosus},
journal = {Australasian Journal of Dermatology},
year = {2025},
doi = {10.1111/ajd.14434}
}
EUVIMED